EC Microbiology

Review Article Volume 17 Issue 2 - 2021

Role of Tonics and Vitamins in Management of Patients with Chronic Diseases

Alaa Omar Alahdal 1, Ali Ahmed Alghamdi 2, Abdullah Sultan Al Qattoumah 3, Turki Bukhetan Alsolami 2, Ahmed Mabruk Almutairi 2, Talal Mohammad Alotaiby 4, Abdulrahman Hamed Albalawi 2, Abdullah Abdulwahab Aljuhani 2, Assel Khalid Binyousef 2, Waleed Adnan Bamarouf 2, and Mohanad Saad Alqarni 2.

1 Consultant in Saudi Commission for Health Specialist, Associate Consultant in National Guard Hospital-Jeddah, Saudi Arabia
2 Collage of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
3 General Physician, Land Forces Medical Administration, Najran, Saudi Arabia
4 Department Of Pediatrics, King Abdulaziz Hospital, Jeddah, Saudi Arabia

*Corresponding Author: Alaa Omar Alahdal, Consultant in Saudi Commission for Health Specialist, Associate Consultant in National Guard Hospital-Jeddah, Saudi Arabia.
Received: January 08, 2021;Published: January 20, 2021



Background: Vitamins and minerals are a diverse group of substances that play an enormous number of roles in the body. Vitamins (vital amines) are organic compounds that are required in trace amounts in the diet because they cannot be synthesized in sufficient quantities by an organism. Vitamins and their metabolites are essential for a large number of physiological processes, fulfilling di- verse functions as hormones and antioxidants.

Aim: In this review, we will look into the role of tonics and vitamins in management of patients with chronic disease

Conclusion:This review concluded that the vitamins had a role in management of chronic disease like cardiovascular die, cancer, diabetes and others. The most common vitamins reported were Vitamin A, Vitamin B, Vitamin C, Vitamin D and Vitamin E. It is im- portant for physicians to identify patients with poor nutrition or other reasons for increased vitamin needs.

 Keywords: Vitamins; Vitamins and Chronic Diseases; Vitamins Importance; Management of Chronic Diseases with Vitamins

  1. Woteki CE and Thomas PR. “Eat for Life: The Food and Nutrition Board’s Guide to Reducing Your Risk of Chronic Disease”. Institute of Medicine (US) Committee on Diet and Health Washington (DC): National Academies Press (US); Chapter 8, Vitamins, Minerals, And Chronic Diseases (1992).
  2. Rosenberg IH. “Challenges and opportunities in the translation of the science of vitamins”. The American Journal of Clinical Nutrition 85 (2007): 325S-327S.
  3. World Health Organisation (WHO). “Noncommunicable Diseases”. (2018).
  4. Oschman JL. “Chronic disease: are we missing something?”. Journal of Alternative and Complementary Medicine 17.4 (2011): 283-285.
  5. World Health Organisation (WHO). “The Top Ten Causes of Death”. (2018).
  6. World Health Organisation (WHO). “Diabetes”. (2018).
  7. Fletcher RH and Fairfield KM. “Vitamins for Chronic Disease Prevention in Adults: Clinical Applications”. The Journal of the American Medical Association 287.23 (2002): 3127-3129.
  8. Yetley EA. “Multivitamin and multimineral dietary supplements: definitions, characterization, bioavailability, and drug interactions”. The American Journal of Clinical Nutrition 85.1 (2007): 269S-276S.
  9. Bailey RL., et al. “Dietary supplement use in the United States, 2003-2006”. Journal of Nutrition 141.2 (2011): 261-266.
  10. Heaney RP. “Vitamin D--baseline status and effective dose”. The New England Journal of Medicine 367.1 (2012): 77.
  11. Valdés-Ramos R., et al. “Vitamins and type 2 diabetes mellitus”. Endocrine, Metabolic and Immune Disorders - Drug Targets 15.1 (2015): 54-63.
  12. Blomhoff R and Blomhoff HK. “Overview of retinoid metabolism and function”. Journal of Neurobiology 66.7 (2006): 606-630.
  13. Brun PJ., et al. “Retinoids: Potent regulators of metabolism”. BioFactors 39.2 (2013): 151-163.
  14. Fairfield KM and Fletcher RH. “Vitamins for Chronic Disease Prevention in Adults: Scientific Review”. The Journal of the American Medical Association 287.23 (2002): 3116-3126.
  15. Willett WC and Hunter DJ. “Vitamin A and cancers of the breast, large bowel, and prostate: epidemiologic evidence”. Nutrition Reviews 52.2 (1994): S53-S59.
  16. Michels KB., et al. “Dietary antioxidant vitamins, retinol, and breast cancer incidence in a cohort of Swedish women”. International Journal of Cancer 91.4 (2001): 563-567.
  17. Liu S., et al. “Intake of vegetables rich in carotenoids and risk of coronary heart disease in men: The Physicians’ Health Study”. International Journal of Epidemiology 30.1 (2001): 130-135.
  18. Kirk GR., et al. “Combined antioxidant therapy reduces pain and improves quality of life in chronic pancreatitis”. The Journal of Gastrointestinal Surgery 10 (2006): 499-503.
  19. Shah NS., et al. “Quality of life assessment in patients with chronic pancreatitis receiving antioxidant therapy”. World Journal of Gastroenterology 16.32 (2010): 4066-4071.
  20. “The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers: the Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group”. The New England Journal of Medicine 330 (1994): 1029-1035.
  21. Dong MH., et al. “Thiamin, riboflavin, and vitamin B6 contents of selected foods as served”. Journal of the American Dietetic Association 76 (1980): 156-160.
  22. Sica DA. “Loop diuretic therapy, thiamine balance, and heart failure”. Congestive Heart Failure 13 (2007): 244-247.
  23. Bostom AG and Garber C. “Endpoints for homocysteine-lowering trials”. Lancet 355 (2000): 511-512.
    24. Sure, here are the sentences in the requested format: ```html
  24. Kim YI. “Folate and cancer prevention: a new medical application of folate beyond hyperhomocysteinemia and neural tube defects”. Nutrition Reviews 57 (1999): 314-321.
  25. Zhang XH., et al. “B6 and colorectal cancer: current evidence and future directions”. World Journal of Gastroenterology 19 (2013): 1005-1010.
  26. Vanderslice JT and Higgs DJ. “Vitamin C content of foods: sample variability”. The American Journal of Clinical Nutrition 54 (1991): 1323S-1327S.
  27. Harris JR. “Ascorbic acid: biochemistry and biomedical cell biology. In: Subcellular Biochemistry”. New York, NY: Plenum Press 25 (1996).
  28. Panel on Dietary Antioxidants and Related Compounds, Institute of Medicine. Chapter 5: Vitamin C. In: Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. A Report of the Institute of Medicine. Washington, DC: National Academy Press (2000): 95 - 185.
  29. Loria CM., et al. “Vitamin C status and mortality in US adults”. The American Journal of Clinical Nutrition 72 (2000): 139-145.
  30. Carr AC and Frei B. “Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans”. The American Journal of Clinical Nutrition 69.6 (1999): 1086-1107.
  31. Panel on Dietary Antioxidants and Related Compounds, Institute of Medicine. Chapter 5: Vitamin C. In: Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. A Report of the Institute of Medicine. Washington, DC: National Academy Press; (2000): 95 - 185.
  32. Gandini S., et al. “Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients”. European Journal of Cancer 36 (2000): 636-646.
  33. Ginter E. “Chenodeoxycholic acid, gallstones and vitamin C”. The New England Journal of Medicine 295 (1976): 1260-1261.
  34. Jacob RA. Chapter 29: Vitamin C. In: Shils ME, Olson JA, Shike M, Ross AC, eds. “Modern Nutrition in Health and Disease”. 9th ed. Baltimore, MD: Williams & Wilkins; (1999): 467-483.
  35. Sauberlich HE. “Pharmacology of vitamin C”. Annual Review of Nutrition 14 (1994): 371 - 391.
  36. Harris JR. Ascorbic acid: biochemistry and biomedical cell biology. In: “Subcellular Biochemistry”. New York, NY: Plenum Press 25 (1996).
  37. Wang H., et al. “Vitamin D and Chronic Diseases”. Aging and Disease 8.3 (2017): 346-353.
  38. Carvalho LS and Sposito AC. “Vitamin D for the prevention of cardiovascular disease: Are we ready for that?”. Atherosclerosis 241 (2015): 729-740.
  39. Ohsawa M., et al. “1alpha,25-dihydroxyvitamin D (3) and its potent synthetic analogs downregulate tissue factor and upregulate thrombomodulin expression in monocytic cells, counteracting the effects of tumor necrosis factor and oxidized LDL”. Circulation 102 (2000): 2867-2872.
  40. Hammad LN., et al. “Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis?”. Journal of Immunotoxicology 10 (2013): 380-386.
  41. Fedirko V., et al. “Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial”. Cancer Prevention Research 2 (2009): 213-223.
  42. Lappe JM., et al. “Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial”. The American Journal of Clinical Nutrition 85(2007): 1586-1591.
  43. Masri OA., et al. “Role of vitamins in gastrointestinal diseases. World Journal of Gastroenterology 21.17(2015): 5191-5209.
  44. Cheng Q., et al. “A novel role for vitamin D: modulation of expression and function of the local renin-angiotensin system in mouse pancreatic islets”. Diabetologia 54 (2011): 2077-2081.
  45. Meydani SN., et al. “Vitamin E supplementation and in vivo immune response in healthy elderly subjects: a randomized controlled trial”. The Journal of the American Medical Association 277 (1997): 1380-1386.
  46. Steiner M. “Vitamin E: more than an antioxidant”. Clinical Cardiology 16 (1993): I16-I18.
  47. Pryor WA. “Vitamin E and heart disease: Basic science to clinical intervention trials”. Free Radical Biology and Medicine 28.1 (2000): 141-164.
  48. Stephens NG., et al. “Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)”. Lancet 347 (1996): 781-786.

Alaa Omar Alahdal., et al. “Role of Tonics and Vitamins in Management of Patients with Chronic Diseases”. EC Microbiology 17.2 (2021): 223-230.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net